ClinicalTrials.Veeva

Menu

Ultrasound Impact in Rheumatoid Arthritis Patient Reported Outcomes (ULTRAPRO)

C

Clínica de Artritis Temprana

Status

Completed

Conditions

Musculoskeletal Ultrasound
Patient Reported Outcomes
Rheumatoid Arthritis

Treatments

Diagnostic Test: MusculoSkeletal Ultrasound

Study type

Interventional

Funder types

Other

Identifiers

NCT03228342
IRE-2218-17/19-1

Details and patient eligibility

About

Evaluate the impact of MusculoSkeletal Ultrasound added to Rheumatoid Arthritis patients classified in remission/low disease activity in terms of Patient Reported Outcomes.

Enrollment

94 patients

Sex

All

Ages

16+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • A clinical diagnosis of RA made at the discretion of the attending experienced rheumatologist.
  • Patients classified in remission/low disease activity

Exclusion criteria

  • <16 years old.
  • Patient with recent trauma in the evaluated joints.
  • Luxation in the MCP, PIP or MTP joints.

Trial design

Primary purpose

Other

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

Double Blind

94 participants in 2 patient groups

Ultrasound shared
Experimental group
Description:
Patient will be assessed with ultrasound (GUS-7 score)
Treatment:
Diagnostic Test: MusculoSkeletal Ultrasound
Diagnostic Test: MusculoSkeletal Ultrasound
Ultrasound not shared
Experimental group
Description:
Patient will be assessed with ultrasound (GUS-7 score)
Treatment:
Diagnostic Test: MusculoSkeletal Ultrasound
Diagnostic Test: MusculoSkeletal Ultrasound

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems